Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published online before print July 16, 2007
Psychosom Med 2007, doi:10.1097/PSY.0b013e3180f61c5c
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill Golden, S.
Right arrow Articles by Lyketsos, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill Golden, S.
Right arrow Articles by Lyketsos, C.
Related Collections
Right arrow Depression
Right arrow Diabetes
© 2007 by American Psychosomatic Society

Original Article


Received September 11, 2006
Returned for revision April 17, 2007

Depression and Type 2 Diabetes Mellitus: The Multiethnic Study of Atherosclerosis

Sherita Hill Golden , MD, MHS, Hochang Benjamin Lee , MD, Pamela J. Schreiner , PhD, Ana Diez Roux , PhD, Annette L. Fitzpatrick , PhD, Moyses Szklo , MD, DrPH, Constantine Lyketsos , MD, MHS


Address correspondence and reprint requests to: Sherita Hill Golden, MD, MHS, E-mail: sahill{at}jhmi.edu.


   Abstract

Objective: To assess the cross-sectional association between depression and glucose tolerance status. Methods: We conducted a study of 6754 White, Black, Hispanic, and Chinese men and women aged 45 to 84 years in the Multiethnic Study of Atherosclerosis (MESA). Depression was defined as Center for Epidemiologic Studies Depression scale score of ≥16 and/or antidepressant use. Glucose tolerance status was defined as normal, impaired fasting glucose (IFG) or Type 2 diabetes mellitus (untreated and treated). Results: In the minimally adjusted model, although depression was not associated with a greater odds of IFG (odds ratio (OR) = 1.01; 95% confidence interval (CI): 0.87-1.18) or untreated diabetes (OR = 1.03; 95% CI: 0.74-1.45), it was associated with a greater odds of treated diabetes (OR = 1.57; 95% CI: 1.27-1.96). This persisted following adjustment for body mass index (OR = 1.52; 95% CI: 1.22-1.90), metabolic (OR = 1.54; 95% CI: 1.23-1.93), and inflammatory (OR=1.53; 95% CI: 1.21-1.92) factors, daily caloric intake and smoking (OR = 1.48; 95% CI: 1.16-1.88), and socioeconomic markers (OR = 1.47; 95% CI: 1.17-1.85). Among individuals with treated diabetes, median depression scores were higher in those with microalbuminuria compared with those without microalbuminuria (median = 7; interquartile range: 3-13 versus median = 6; interquartile range: 2-11; p = .046). Depression scores were not associated with homeostatic model assessment of insulin resistance among individuals without diabetes. Conclusions: In MESA, depression was significantly associated with treated diabetes. Further studies are needed to determine the temporality of this association.

Key Words: diabetes mellitus, impaired fasting glucose, depression, epidemiology, insulin resistance.




This article has been cited by other articles:


Home page
JAMAHome page
S. H. Golden, M. Lazo, M. Carnethon, A. G. Bertoni, P. J. Schreiner, A. V. D. Roux, H. B. Lee, and C. Lyketsos
Examining a Bidirectional Association Between Depressive Symptoms and Diabetes
JAMA, June 18, 2008; 299(23): 2751 - 2759.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Psychosomatic Society